Your browser doesn't support javascript.
loading
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
Sharma, Akshay; Leonard, Alexis; West, Kamille; Gossett, Jeffrey M; Uchida, Naoya; Panch, Sandhya; Stroncek, David; Poston, Leigh; Akel, Salem; Hankins, Jane S; Fitzhugh, Courtney; Hsieh, Matthew M; Kang, Guolian; Tisdale, John F; Weiss, Mitchell J; Zheng, Yan.
Affiliation
  • Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Leonard A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA.
  • West K; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Gossett JM; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA.
  • Panch S; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Stroncek D; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Poston L; Human Applications Lab, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Akel S; Human Applications Lab, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Hankins JS; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Fitzhugh C; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA.
  • Hsieh MM; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA.
  • Kang G; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA.
  • Weiss MJ; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Zheng Y; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Br J Haematol ; 198(4): 740-744, 2022 08.
Article in En | MEDLINE | ID: mdl-35737751
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Blood Component Removal / Heterocyclic Compounds / Anemia, Sickle Cell Limits: Adult / Humans Language: En Journal: Br J Haematol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Blood Component Removal / Heterocyclic Compounds / Anemia, Sickle Cell Limits: Adult / Humans Language: En Journal: Br J Haematol Year: 2022 Type: Article Affiliation country: United States